Jaipur, Nov. 20 -- Meditation may trigger biological changes linked to pathways targeted by several brain-active medicines, a study by researchers at the Indian Institute of Technology (IIT) Jodhpur has found. The research identified molecular signatures associated with meditation that overlapped with those of 438 pharmaceutical compounds, offering new insights into how meditation may influence brain functioning. The study, titled 'Meditation as a Bioactive Intervention: Evidence of Translational Potential via Connectivity Mapping and TMS Neurophysiology', was published in the international peer-reviewed journal Frontiers in Human Neuroscience on November 9. The research was led by Prof. Mitali Mukerji, who works in Ayurgenomics, and her PhD student Aditi Joshi, in collaboration with Dr Vignesh Muralidharan from the department of bioscience and bioengineering and Deep Patel, a former BTech student from the department of computer science and engineering, currently at Yale University. The researchers analysed publicly available gene expression data from 106 participants in an Inner Engineering meditation retreat. They examined 389 biological profiles collected at four stages - before the programme, after an eight-week preparatory phase, eight days after the meditation retreat and three months later. Using a computational technique called Connectivity Map (CMap), the team compared meditation-associated changes in gene activity with biological signatures produced by pharmaceutical compounds. The analysis identified overlaps with 438 compounds, particularly those targeting pathways associated with GABA, glutamate, dopamine and serotonin - chemical messengers involved in communication between nerve cells. The study also highlighted the neuroactive ligand-receptor interaction pathway, which plays an important role in regulating communication between nerve cells. Researchers further explored the relationship between these molecular changes and the brain's excitation-inhibition balance, which regulates the activation and suppression of nerve-cell activity and is important for attention, emotional regulation, learning and movement. For this, they examined published studies on the effects of 75 drugs across 55 drug classes and 21 measures of brain activity using transcranial magnetic stimulation (TMS), a non-invasive technique. The findings suggested that meditation-associated molecular changes shared certain pathways with those influenced by drugs acting on GABA, glutamate and other neurotransmitter systems. The molecular signatures also varied across the preparatory, intensive meditation and follow-up phases, indicating differences in biological responses over time. The researchers cautioned that the findings do not establish that meditation works like these medicines or can replace medical treatment. The study was exploratory, relied on an existing dataset and did not directly measure participants' brain activity using TMS. Since the gene expression data came from blood samples, they may not directly reflect changes within the brain. Professor Mukerji said the research aimed to examine whether the effects of meditation could be understood through measurable biological changes, beyond its established association with mental wellbeing. The team has proposed further studies combining molecular analysis with TMS, electromyography (EMG) and electroencephalography to directly investigate changes in brain activity following meditation....